Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of RBAK mRNA | CTD | PMID:21570461 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Rbak (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of RBAK mRNA | CTD | PMID:33387578 | 4,4'-diaminodiphenylmethane | increases expression | EXP | | 6480464 | 4 and 4'-diaminodiphenylmethane results in increased expression of RBAK mRNA | CTD | PMID:18648102 | 4-hydroxyphenyl retinamide | increases expression | ISO | RBAK (Homo sapiens) | 6480464 | Fenretinide results in increased expression of RBAK mRNA | CTD | PMID:16570282 | acrylamide | increases expression | ISO | RBAK (Homo sapiens) | 6480464 | Acrylamide results in increased expression of RBAK mRNA | CTD | PMID:32763439 | aflatoxin B1 | decreases expression | ISO | Rbak (Rattus norvegicus) | 6480464 | Aflatoxin B1 results in decreased expression of RBAK mRNA | CTD | PMID:33354967 | aflatoxin M1 | decreases expression | ISO | RBAK (Homo sapiens) | 6480464 | Aflatoxin M1 results in decreased expression of RBAK mRNA | CTD | PMID:30928695 | aristolochic acid A | decreases expression | ISO | RBAK (Homo sapiens) | 6480464 | aristolochic acid I results in decreased expression of RBAK mRNA | CTD | PMID:33212167 | Aroclor 1254 | decreases expression | ISO | RBAK (Homo sapiens) | 6480464 | Chlorodiphenyl (54% Chlorine) results in decreased expression of RBAK mRNA | CTD | PMID:16934159 | bisphenol A | affects expression | ISO | Rbak (Rattus norvegicus) | 6480464 | bisphenol A affects the expression of RBAK mRNA | CTD | PMID:25181051 | bisphenol A | decreases expression | ISO | Rbak (Rattus norvegicus) | 6480464 | bisphenol A results in decreased expression of RBAK mRNA | CTD | PMID:34947998 | bisphenol A | decreases methylation | ISO | Rbak (Rattus norvegicus) | 6480464 | bisphenol A results in decreased methylation of RBAK gene | CTD | PMID:28505145 | butanal | decreases expression | ISO | RBAK (Homo sapiens) | 6480464 | butyraldehyde results in decreased expression of RBAK mRNA | CTD | PMID:26079696 | carbon nanotube | decreases expression | EXP | | 6480464 | Nanotubes more ... | CTD | PMID:25554681 | chlorpyrifos | decreases expression | EXP | | 6480464 | Chlorpyrifos results in decreased expression of RBAK mRNA | CTD | PMID:37019170 | copper(II) sulfate | increases expression | ISO | RBAK (Homo sapiens) | 6480464 | Copper Sulfate results in increased expression of RBAK mRNA | CTD | PMID:19549813 | dicrotophos | decreases expression | ISO | RBAK (Homo sapiens) | 6480464 | dicrotophos results in decreased expression of RBAK mRNA | CTD | PMID:28302478 | dorsomorphin | multiple interactions | ISO | RBAK (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | doxorubicin | affects expression | ISO | RBAK (Homo sapiens) | 6480464 | Doxorubicin affects the expression of RBAK mRNA | CTD | PMID:29803840 | ferric oxide | increases expression | EXP | | 6480464 | ferric oxide analog results in increased expression of RBAK mRNA | CTD | PMID:24525745 | folic acid | decreases expression | EXP | | 6480464 | Folic Acid results in decreased expression of RBAK mRNA | CTD | PMID:25629700 | formaldehyde | decreases expression | ISO | RBAK (Homo sapiens) | 6480464 | Formaldehyde results in decreased expression of RBAK mRNA | CTD | PMID:20655997 | geldanamycin | increases expression | ISO | RBAK (Homo sapiens) | 6480464 | geldanamycin results in increased expression of RBAK mRNA | CTD | PMID:26705709 | gentamycin | decreases expression | ISO | Rbak (Rattus norvegicus) | 6480464 | Gentamicins results in decreased expression of RBAK mRNA | CTD | PMID:33387578 | mercury dichloride | decreases expression | ISO | RBAK (Homo sapiens) | 6480464 | Mercuric Chloride results in decreased expression of RBAK mRNA | CTD | PMID:27188386 | methotrexate | affects expression | EXP | | 6480464 | Methotrexate affects the expression of RBAK mRNA | CTD | PMID:18502557 | methylmercury chloride | increases expression | ISO | RBAK (Homo sapiens) | 6480464 | methylmercuric chloride results in increased expression of RBAK mRNA | CTD | PMID:26272509 | methylmercury chloride | decreases expression | ISO | RBAK (Homo sapiens) | 6480464 | methylmercuric chloride results in decreased expression of RBAK mRNA | CTD | PMID:28001369 | p-chloromercuribenzoic acid | increases expression | ISO | RBAK (Homo sapiens) | 6480464 | p-Chloromercuribenzoic Acid results in increased expression of RBAK mRNA | CTD | PMID:27188386 | pentanal | decreases expression | ISO | RBAK (Homo sapiens) | 6480464 | pentanal results in decreased expression of RBAK mRNA | CTD | PMID:26079696 | phenylmercury acetate | decreases expression | ISO | RBAK (Homo sapiens) | 6480464 | Phenylmercuric Acetate results in decreased expression of RBAK mRNA | CTD | PMID:26272509 | phenylmercury acetate | multiple interactions | ISO | RBAK (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RBAK mRNA | CTD | PMID:27188386 | pirinixic acid | multiple interactions | EXP | | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of RBAK mRNA | CTD | PMID:19710929 | quercitrin | increases expression | ISO | RBAK (Homo sapiens) | 6480464 | quercitrin results in increased expression of RBAK mRNA | CTD | PMID:25193878 | resveratrol | multiple interactions | ISO | RBAK (Homo sapiens) | 6480464 | [Plant Extracts co-treated with Resveratrol] results in increased expression of RBAK mRNA | CTD | PMID:23557933 | SB 431542 | multiple interactions | ISO | RBAK (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | sunitinib | increases expression | ISO | RBAK (Homo sapiens) | 6480464 | Sunitinib results in increased expression of RBAK mRNA | CTD | PMID:31533062 | thimerosal | decreases expression | ISO | RBAK (Homo sapiens) | 6480464 | Thimerosal results in decreased expression of RBAK mRNA | CTD | PMID:27188386 | titanium dioxide | affects expression | EXP | | 6480464 | titanium dioxide affects the expression of RBAK mRNA | CTD | PMID:17656681 | trichostatin A | decreases expression | ISO | RBAK (Homo sapiens) | 6480464 | trichostatin A results in decreased expression of RBAK mRNA | CTD | PMID:24935251 and PMID:26272509 | trichostatin A | multiple interactions | ISO | RBAK (Homo sapiens) | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RBAK mRNA | CTD | PMID:27188386 | triptonide | decreases expression | EXP | | 6480464 | triptonide results in decreased expression of RBAK mRNA | CTD | PMID:33045310 | trovafloxacin | increases expression | EXP | | 6480464 | trovafloxacin results in increased expression of RBAK mRNA | CTD | PMID:35537566 | valproic acid | decreases expression | ISO | RBAK (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of RBAK mRNA | CTD | PMID:23179753 more ... | valproic acid | multiple interactions | ISO | RBAK (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RBAK mRNA | CTD | PMID:27188386 | vinclozolin | increases methylation | ISO | Rbak (Rattus norvegicus) | 6480464 | vinclozolin results in increased methylation of RBAK gene | CTD | PMID:31079544 | vorinostat | decreases expression | ISO | RBAK (Homo sapiens) | 6480464 | vorinostat results in decreased expression of RBAK mRNA | CTD | PMID:27188386 | |